Mike Dennis
Overview
Explore the profile of Mike Dennis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Cham Y, Kondor A, Kontturi E, Stone C, Dennis M, et al.
Carbohydr Polym
. 2025 Feb;
354:123292.
PMID: 39978915
Water is commonly considered as the optimal dispersing medium for nanocellulose given its hydrophilic nature. However, studies have also proven otherwise that alternative organic solvents may give better dispersion quality....
2.
Venditti A, Palmieri R, Maurillo L, Rollig C, Wierzbowska A, De Leeuw D, et al.
Blood Adv
. 2025 Feb;
PMID: 39913928
Fitness assessment in patients with acute myeloid leukemia (AML) is critical to deliver the right therapy to the right patient. While several scoring systems are available to aid in determining...
3.
Peralta-Alvarez M, Downward K, White A, Azema H, Sibley L, Sarfas C, et al.
NPJ Vaccines
. 2024 Nov;
9(1):230.
PMID: 39567530
The only currently licensed vaccine against tuberculosis (TB), Bacille Calmette Guérin (BCG), is insufficient to control the epidemic. MTBVAC is a live attenuated strain of Mycobacterium tuberculosis (M.tb) and is...
4.
Russell N, Thomas A, Hills R, Thomas I, Gilkes A, Almuina N, et al.
J Clin Oncol
. 2024 Nov;
43(6):694-704.
PMID: 39556780
Purpose: To evaluate the survival benefit of chemotherapy intensification in older patients with AML who have not achieved a measurable residual disease (MRD)-negative remission. Methods: Five hundred twenty-three patients with...
5.
Peralta Alvarez M, Downward K, White A, Harris S, Satti I, Li S, et al.
Vaccine
. 2024 Nov;
42(26):126444.
PMID: 39522337
A new and more effective tuberculosis (TB) vaccine is urgently needed, but development is hampered by the lack of validated immune correlates of protection. Bacillus Calmette Guérin (BCG) vaccination by...
6.
Othman J, Hwang A, Brodermann M, Abdallah I, McCloskey K, Gallipoli P, et al.
Blood Adv
. 2024 Sep;
8(21):5590-5597.
PMID: 39265176
Gilteritinib is the current standard of care for relapsed or refractory fms related receptor tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia in many countries, however outcomes for patients relapsing after...
7.
Versluis J, Metzner M, Wang A, Gradowska P, Thomas A, Jakobsen N, et al.
J Clin Oncol
. 2024 Sep;
42(34):4084-4094.
PMID: 39231389
Purpose: AML is a genetically heterogeneous disease, particularly in older patients. In patients older than 60 years, survival rates are variable after the most important curative approach, intensive chemotherapy followed...
8.
Dennis M, Charlton M, Elam S, Wolfensohn S
Lab Anim
. 2024 Aug;
:236772241247104.
PMID: 39118535
UK Health Security Agency is required to investigate the pathogenesis of emerging or re-emerging infections and to test novel interventions, such as vaccines and therapeutics against these and other diseases,...
9.
Sibley L, Sarfas C, Morrison A, Williams J, Gkolfinos K, Mabbutt A, et al.
Sci Rep
. 2024 Jul;
14(1):16993.
PMID: 39043848
The BCG vaccine is given to millions of children globally but efficacy wanes over time and differences in the immune systems between infants and adults can influence vaccine efficacy. To...
10.
Peralta Alvarez M, Jones H, Azema H, Davis C, White A, Sarfas C, et al.
Front Immunol
. 2024 May;
15:1387454.
PMID: 38799468
Introduction: Mycobacteria are known to exert a range of heterologous effects on the immune system. The mycobacteria-based Freund's Complete Adjuvant is a potent non-specific stimulator of the immune response used...